SI010192: Acalabrutinib Metabolite [AC-5862]-d4 Pack Size:1 mg 65 / An Fmoc-protected L-threonine

65 / An Fmoc-protected L-threonine building block carrying an α-D-glucose residue

β-D-GalNAc(Ac)3-Et-Azide

38 / A β-D-galactose ligand equipped with a free thiol through a hydrophilic PEG3 spacer

Abnormal Akt signaling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells

and other amine-reactive groups to form stable amide bonds with the Tri-GalNAc ligand

SI010192: Acalabrutinib Metabolite [AC-5862]-d4 Pack Size:1 mg 65 / An Fmoc-protected L-threonineC26H19D4N7O2 469. 5 Acalabrutinib Metabolite [AC 5862] d4 AC 5862 d4; 4 [8 Amino 3 [1 oxo 4 [(1 oxo 2 butyn 1 yl)amino]butyl]imidazo[1,5 a]pyrazin 1 yl] N 2 pyridinyl benzamide d4